GLAND.NS(GLAND.NS)
GLAND.NS
$2922.30—Stale · unknown old
NSE • Last print unknown ago
$2922.30—Stale · unknown old
No analyst ratings available
No analyst price targets available for GLAND.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $74.50B | $85.17B | $97.96B |
| Low | $71.28B | $81.92B | $93.69B |
| High | $77.31B | $88.55B | $104.41B |
| EBITDA Avg | $23.51B | $27.77B | $32.67B |
| Low | $22.18B | $25.85B | $29.13B |
| High | $26.06B | $30.81B | $37.05B |
| EBIT Avg | $18.95B | $22.78B | $27.13B |
| Low | $17.62B | $20.86B | $23.60B |
| High | $21.50B | $25.82B | $31.51B |
| Net Income Avg | $13.18B | $15.89B | $18.96B |
| Low | $12.24B | $14.53B | $16.46B |
| High | $14.98B | $18.03B | $22.05B |
| EPS Avg | $81.32 | $98.78 | $115.21 |
| Low | $74.22 | $88.10 | $99.81 |
| High | $90.84 | $109.32 | $133.69 |
| Analysts (Rev / EPS) | 14 / 13 | 14 / 13 | 9 / 7 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $17.33B | $19.05B | $19.20B | $20.87B |
| Low | $16.93B | $18.22B | $18.56B | $20.17B |
| High | $17.65B | $19.53B | $19.63B | $21.33B |
| EBITDA Avg | $5.12B | $6.01B | $6.30B | $6.34B |
| Low | $4.93B | $5.84B | $6.08B | $6.11B |
| High | $5.46B | $6.20B | $6.45B | $6.48B |
| EBIT Avg | $3.99B | $4.87B | $5.14B | $5.15B |
| Low | $3.81B | $4.70B | $4.92B | $4.93B |
| High | $4.33B | $5.06B | $5.28B | $5.30B |
| Net Income Avg | $2.78B | $3.39B | $3.58B | $3.59B |
| Low | $2.65B | $3.27B | $3.43B | $3.44B |
| High | $3.02B | $3.53B | $3.69B | $3.70B |
| EPS Avg | $16.83 | $20.58 | $21.74 | $21.79 |
| Low | $16.04 | $19.85 | $20.79 | $20.84 |
| High | $18.29 | $21.40 | $22.36 | $22.42 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 1 / 1 | 1 / 1 |